BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Piyush R, Rajarshi K, Chatterjee A, Khan R, Ray S. Nucleic acid-based therapy for coronavirus disease 2019. Heliyon 2020;6:e05007. [PMID: 32984620 DOI: 10.1016/j.heliyon.2020.e05007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Belete TM. Review on Up-to-Date Status of Candidate Vaccines for COVID-19 Disease. Infect Drug Resist 2021;14:151-61. [PMID: 33500636 DOI: 10.2147/IDR.S288877] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 11.0] [Reference Citation Analysis]
2 Ayad C, Libeau P, Lacroix-Gimon C, Ladavière C, Verrier B. LipoParticles: Lipid-Coated PLA Nanoparticles Enhanced In Vitro mRNA Transfection Compared to Liposomes. Pharmaceutics 2021;13:377. [PMID: 33809164 DOI: 10.3390/pharmaceutics13030377] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
3 Cennamo N, Pasquardini L, Arcadio F, Lunelli L, Vanzetti L, Carafa V, Altucci L, Zeni L. SARS-CoV-2 spike protein detection through a plasmonic D-shaped plastic optical fiber aptasensor. Talanta 2021;233:122532. [PMID: 34215035 DOI: 10.1016/j.talanta.2021.122532] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
4 Abusalah MAH, Khalifa M, Al-hatamleh MAI, Jarrar M, Mohamud R, Chan YY. Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm. JPM 2022;12:386. [DOI: 10.3390/jpm12030386] [Reference Citation Analysis]
5 Chavda VP, Hossain MK, Beladiya J, Apostolopoulos V. Nucleic Acid Vaccines for COVID-19: A Paradigm Shift in the Vaccine Development Arena. Biologics 2021;1:337-56. [DOI: 10.3390/biologics1030020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Das S, Kar SS, Samanta S, Banerjee J, Giri B, Dash SK. Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review. Immunol Res 2022. [PMID: 35192185 DOI: 10.1007/s12026-022-09265-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Weisshoff H, Krylova O, Nikolenko H, Düngen HD, Dallmann A, Becker S, Göttel P, Müller J, Haberland A. Aptamer BC 007 - Efficient binder of spreading-crucial SARS-CoV-2 proteins. Heliyon 2020;6:e05421. [PMID: 33163683 DOI: 10.1016/j.heliyon.2020.e05421] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Khanali J, Azangou-Khyavy M, Asaadi Y, Jamalkhah M, Kiani J. Nucleic Acid-Based Treatments Against COVID-19: Potential Efficacy of Aptamers and siRNAs. Front Microbiol 2021;12:758948. [PMID: 34858370 DOI: 10.3389/fmicb.2021.758948] [Reference Citation Analysis]
9 Gasparello J, Finotti A, Gambari R. Tackling the COVID-19 "cytokine storm" with microRNA mimics directly targeting the 3'UTR of pro-inflammatory mRNAs. Med Hypotheses 2021;146:110415. [PMID: 33422363 DOI: 10.1016/j.mehy.2020.110415] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
10 Montazeri Aliabadi H, Totonchy J, Mahdipoor P, Parang K, Uludağ H. Suppression of Human Coronavirus 229E Infection in Lung Fibroblast Cells via RNA Interference. Front Nanotechnol 2021;3:670543. [DOI: 10.3389/fnano.2021.670543] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
11 Laliberté-Gagné ME, Bolduc M, Garneau C, Olivera-Ugarte SM, Savard P, Leclerc D. Modulation of Antigen Display on PapMV Nanoparticles Influences Its Immunogenicity. Vaccines (Basel) 2021;9:33. [PMID: 33435570 DOI: 10.3390/vaccines9010033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Quemener AM, Galibert MD. Antisense oligonucleotide: A promising therapeutic option to beat COVID-19. Wiley Interdiscip Rev RNA 2021;:e1703. [PMID: 34842345 DOI: 10.1002/wrna.1703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Raoufi E, Bahramimeimandi B, Salehi-Shadkami M, Chaosri P, Mozafari MR. Methodical Design of Viral Vaccines Based on Avant-Garde Nanocarriers: A Multi-Domain Narrative Review. Biomedicines 2021;9:520. [PMID: 34066608 DOI: 10.3390/biomedicines9050520] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Staroseletz Y, Gaponova S, Patutina O, Bichenkova E, Amirloo B, Heyman T, Chiglintseva D, Zenkova M. Site-Selective Artificial Ribonucleases: Renaissance of Oligonucleotide Conjugates for Irreversible Cleavage of RNA Sequences. Molecules 2021;26:1732. [PMID: 33808835 DOI: 10.3390/molecules26061732] [Reference Citation Analysis]